April 15, 2024

Azurity Prescription drugs has recalled an ADHD and narcolepsy medicine after the incorrect drugs had been found in considered one of its bottles.

The recall discover, which applies to a batch of Zenzedi 30 milligram tablets, got here after a pharmacist in Nebraska discovered tablets of carbinoxamine maleate, an antihistamine drug, in a bottle labeled Zenzedi. 

Zenzedi is a stimulant, whereas carbinoxamine maleate is a sedative, and has the other impact on the physique.

“Sufferers who take carbinoxamine as an alternative of Zenzedi will expertise undertreatment of their signs, which can end in purposeful impairment and an elevated danger of accidents or harm,” Azurity stated in its recall discover.

Those that unknowingly ingest carbinoxamine may expertise sleepiness, drowsiness, central nervous system melancholy, elevated eye stress, enlarged prostate urinary obstruction, and thyroid dysfunction, the corporate stated.

Azurity stated there is a good likelihood these with ADHD or narcolepsy who as an alternative proceed to eat carbinoxamine, may expertise ongoing incapacity or dying in extreme instances — once they have interaction in actions requiring alertness and focus, like working heavy equipment.

There have up to now been no experiences of significant antagonistic results or occasions regarding the recall.

Zenzedi might be recognized as a light-weight yellow hexagonal pill with the quantity 30 etched on one aspect and “MIA” carved into the opposite.


The suspect tablets — recognized by the pharmacist as “carbinoxamine maleate tablets USP, 4 mg” — are white and spherical with “GL” debossed on one aspect and “211” on the opposite.

The product was distributed to pharmacies nationwide.

For extra info on the recall, or to submit a report regarding it, click on right here.

Supply Hyperlink : beastpower.co.uk